Showing results (811-820 of 1,111) with videos related to
Sort By:
Pageof 112
Human Fertility (Cambridge, England)|July 4, 2017
The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenismElena Grodnitskaya, Mark KurtserHuman Fertility (Cambridge, England)|August 14, 2026
Experiences of insemination fraud: discovering and navigating unexpected and entangled connectionsAstrid Indekeu, Merel Gootjes, Paul Enzlin, et al.Human Fertility (Cambridge, England)|August 27, 2026
A longer time interval between operative hysteroscopy and intrauterine insemination is negatively associated with pregnancy outcomesDavid Boedeker, Meghan Yamasaki, Kiley Hunkler, et al.Human Fertility (Cambridge, England)|September 21, 2026
The correlation between maternal expression of miR-146b and repeated failure of frozen-thawed embryo transfer pregnancyYina Wu, Qingqing Zhou, Xiali Zhao, et al.Human Fertility (Cambridge, England)|June 28, 2022
Does male fertility-related quality of life differ when undergoing evaluation by reproductive urologist versus reproductive endocrinologist?Rachel Danis, Intira Sriprasert, William Petok, et al.Human Fertility (Cambridge, England)|July 6, 2022
Recombinant human granulocyte colony stimulating factor (rhG-CSF) participates in the progression of implantation via the hsa_circ_0001550-miRNA-mRNA interaction networkMeng Lyu, Anchen Su, Lili Zhang, et al.Human Fertility (Cambridge, England)|October 14, 2020
The impact of emotional health on assisted reproductive technology outcomes: a systematic review and meta-analysisGrace Peaston, Venkatesh Subramanian, Oliver Brunckhorst, et al.Human Fertility (Cambridge, England)|January 18, 2020
Fertilisation and early embryonic development of immature and rescue in vitro-matured sibling oocytesBerrin Avci, Isil Kasapoglu, Cihan Cakir, et al.Human Fertility (Cambridge, England)|January 13, 2021
COVID-19 and hypogonadism: secondary immune responses rule-over endocrine mechanismsPallav Sengupta, Sulagna DuttaHuman Fertility (Cambridge, England)|January 16, 2023
FSH administration at 12-hour intervals for the first 2 days, combined with mandatory GnRH-agonist trigger and blastocyst vitrification in women (<80Kg) with high AMH levels, results in higher cumulative live birth rates and is saferRichard Fleming, Mariano Mascarenhas, Frances Roebuck, et al.Pageof 112